Citations

Clear

634 citation(s) found for "Hall, A".

Poly (ADP-Ribose) Polymerase Inhibitors: Recent Advances and Future Development
Scott, Clare L. , Swisher, Elizabeth M. , Kaufmann, Scott H. , Kaufmann, Scott H , Swisher, Elizabeth M , Scott, Clare L

Mayo Clinic

Journal of Clinical Oncology | March 17, 2015 | Volume: 33 | Issue: 12 | Pages: 1397-1406

10.1200/jco.2014.58.8848 | PMID 25779564 Get It

Poly (ADP-ribose) polymerase (PARP) inhibitors have shown promising activity in epithelial ovarian cancers, especially relapsed platinum-sensitive high-grade serous disease. Consistent with preclinical studies, ovarian cancers and a number of other solid tumor types occurring in patients with deleterious germline mutations in BRCA1 or BRCA2 seem to be particularly sensitive. However, it is also becoming clear that germline BRCA1/2 mutations are neither necessary nor sufficient for patients to derive benefit from PARP inhibitors. We provide an update on PARP inhibitor clinical development, describe recent advances in our understanding of PARP inhibitor mechanism of action, and discuss current issues in the development of these agents.
Continuous Age- and Sex-Adjusted Reference Intervals of Urinary Markers for Cerebral Creatine Deficiency Syndromes: A Novel Approach to the Definition of Reference Intervals
Mørkrid, Lars , Rowe, Alexander D. , Elgstøen, Katja Benedikte Prestø , Olesen, Jess Have, Ruijter, George J. G. , Tortorelli, Silvia , Kyriakopoulou, Lianna , Wamelink, Mirjam M. C. , Kamp, Jiddeke M. van de , Salomons, Gajja S. , Rinaldo, Piero, Hall, Patricia , Schulze, Andreas

Mayo Clinic

Clinical Chemistry | March 10, 2015 | Volume: 61 | Issue: 5 | Pages: 760-768

10.1373/clinchem.2014.235564 | PMID 25759465 Get It

Abstract BACKGROUND Urinary concentrations of creatine and guanidinoacetic acid divided by creatinine are informative markers for cerebral creatine deficiency syndromes (CDSs). The renal excretion of these substances varies substantially with age and sex, challenging the sensitivity and specificity of postanalytical interpretation. METHODS Results from 155 patients with CDS and 12 507 reference individuals were contributed by 5 diagnostic laboratories. They were binned into 104 adjacent age intervals and renormalized with Box–Cox transforms (Ξ). Estimates for central tendency (μ) and dispersion (σ) of Ξ were obtained for each bin. Polynomial regression analysis was used to establish the age dependence of both μ[log(age)] and σ[log(age)]. The regression residuals were then calculated as z-scores = {Ξ − μ[log(age)]}/σ[log(age)]. The process was iterated until all z-scores outside Tukey fences ±3.372 were identified and removed. Continuous percentile charts were then calculated and plotted by retransformation. RESULTS Statistically significant and biologically relevant subgroups of z-scores were identified. Significantly higher marker values were seen in females than males, necessitating separate reference intervals in both adolescents and adults. Comparison between our reconstructed reference percentiles and current standard age-matched reference intervals highlights an underlying risk of false-positive and false-negative events at certain ages. CONCLUSIONS Disease markers depending strongly on covariates such as age and sex require large numbers of reference individuals to establish peripheral percentiles with sufficient precision. This is feasible only through collaborative data sharing and the use of appropriate statistical methods. Broad application of this approach can be implemented through freely available Web-based software.
Research Priorities for the Influence of Gender on Diagnostic Imaging Choices in the Emergency Department Setting
Ashurst, John , Cherney, Alan R., Evans, Elizabeth , Hall, M. Kennedy , Kline, Jeffrey A. , Mitchell, Alice M. , Mills, Angela M. , Weigner, Michael B., Hess, Erik P. , Moore, Christopher L. , Mills, Angela M

Mayo Clinic

Academic Emergency Medicine | November 24, 2014 | Volume: 21 | Issue: 12 | Pages: 1431-1437

10.1111/acem.12537 | PMID 25420885 Get It

Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk
Painter, Jodie N. , Batra, Jyotsna , Cheng, Timothy, Lose, Felicity , Dennis, Joe, Michailidou, Kyriaki , Ahmed, Shahana, Ferguson, Kaltin , Healey, Catherine S., Kaufmann, S., Hillman, Kristine M. , Walpole, Carina , Moya, Leire , Pollock, Pamela M. , Jones, Angela, Howarth, Kimberley, Martin, L. J., Gorman, Maggie, Hodgson, Shirley, (NSECG), National Study of Endometrial Cancer Genetics Group, Polanco, Ma. Magdalena Echeverry De, Sans, Monica, Carracedo, Angel, Castellvi-Bel, Sergi, Rojas-Martinez, Augusto, Santos, Erika, Teixeira, Manuel R., Carvajal-Carmona, Luis, Shu, Xiao-Ou, Long, Jirong, Zheng, Wei, Xiang, Yong-Bing, (ANECS), The Australian National Endometrial Cancer Study Group, Montgomery, Grant W., Webb, Penelope M., Scott, Rodney J., McEvoy, Mark, Attia, John, Holliday, Elizabeth, Martin, Nicholas G., Nyholt, Dale R., Henders, Anjali K., Fasching, Peter A., Hein, Alexander, Beckmann, Matthias W., Renner, Stefan P., Dörk, Thilo, Hillemanns, Peter, Dürst, Matthias, Runnebaum, Ingo, Lambrechts, Diether, Coenegrachts, Lieve, Schrauwen, Stefanie, Amant, Frederic, Winterhoff, Boris, Dowdy, Sean C., Goode, Ellen L., Teoman, Attila, Salvesen, Helga B., Trovik, Jone, Njolstad, Tormund S., Werner, Henrica M.J., Ashton, Katie, Proietto, Tony, Otton, Geoffrey, Tzortzatos, Gerasimos, Mints, Miriam, Tham, Emma, RENDOCAS, Hall, Per, Czene, Kamila, Liu, Jianjun, Li, Jingmei, Hopper, John L., Southey, Melissa C., (AOCS), Australian Ovarian Cancer Study, Ekici, Arif B., Ruebner, Matthias, Johnson, Nicola, Peto, Julian, Burwinkel, Barbara, Marme, Frederik, Brenner, Hermann, Dieffenbach, Aida K., Meindl, Alfons, Brauch, Hiltrud, Network, The GENICA, Lindblom, Annika, Depreeuw, Jeroen, Moisse, Matthieu, Chang-Claude, Jenny, Rudolph, Anja, Couch, Fergus J., Olson, Janet E., Giles, Graham G., Bruinsma, Fiona, Cunningham, Julie M., Fridley, Brooke L., Børresen-Dale, Anne-Lise, Kristensen, Vessela N., Cox, Angela, Swerdlow, Anthony J., Orr, Nicholas, Bolla, Manjeet K., Wang, Qin, Weber, Rachel Palmieri, Chen, Zhihua, Shah, Mitul, French, Juliet D., Pharoah, Paul D.P., Dunning, Alison M., Tomlinson, Ian, Easton, Douglas F., Edwards, Stacey L., Thompson, Deborah J., Spurdle, Amanda B., Webb, Penelope M. , Chenevix‐Trench, Georgia , Spurdle, Amanda B. , Brauch, Hiltrud , Dörk, Thilo , Cox, Angela , Giles, Graham G. , Southey, Melissa C. , Zheng, Wei , Shu, Xiao‐Ou , Long, Jirong , Dunning, Alison M. , Lindblom, Annika , Ekici, Arif B. , Czene, Kamila , Liu, Jianjun , Carracedo, Ángel , Hein, Alexander , Hillemanns, Peter , Lambrechts, Diether , Martin, Nicholas G. , Montgomery, Grant W. , Brenner, Hermann , Swerdlow, Anthony J. , Orr, Nick , Li, Jingmei , Bowtell, David D.L. , Weber, Rachel Palmieri , Nyholt, Dale R. , Rabstein, Sylvia , Lotz, Anne , Moisse, Matthieu , Teixeira, Manuel R. , French, Juliet D. , McEvoy, Mark , Njølstad, Tormund S. , Tham, Emma , Renner, Stefan P. , Henders, Anjali K. , Lambrechts, Diether , Rogatto, Sílvia Regina , Nicklin, James , Scott, Rodney J. , O’Mara, Tracy A. , Cheng, Timothy, Dennis, Joe, Tyrer, Jonathan P. , Ahmed, Shahana, Jones, Angela, Howarth, Kimberley, Gorman, Maggie, (NSECG), National Study of Endometrial Cancer Genetics Group, Polanco, Ma. Magdalena Echeverry De, Sans, Monica, Carracedo, Angel, Castellvi-Bel, Sergi, Rojas-Martinez, Augusto, Santos, Erika, Teixeira, Manuel R., Carvajal-Carmona, Luis, Shu, Xiao-Ou, Long, Jirong, Zheng, Wei, Xiang, Yong-Bing, (ANECS), The Australian National Endometrial Cancer Study Group, Montgomery, Grant W., Webb, Penelope M., Scott, Rodney J., McEvoy, Mark, Attia, John, Holliday, Elizabeth, Martin, Nicholas G., Nyholt, Dale R., Henders, Anjali K., Fasching, Peter A., Hein, Alexander, Beckmann, Matthias W., Renner, Stefan P., Dörk, Thilo, Hillemanns, Peter, Dürst, Matthias, Runnebaum, Ingo, Lambrechts, Diether, Coenegrachts, Lieve, Schrauwen, Stefanie, Amant, Frederic, Winterhoff, Boris, Dowdy, Sean C., Goode, Ellen L., Teoman, Attila, Salvesen, Helga B., Trovik, Jone, Njolstad, Tormund S., Werner, Henrica M.J., Ashton, Katie, Proietto, Tony, Otton, Geoffrey, Tzortzatos, Gerasimos, Mints, Miriam, Tham, Emma, RENDOCAS, Hall, Per, Czene, Kamila, Liu, Jianjun, Li, Jingmei, Hopper, John L., Southey, Melissa C., (AOCS), Australian Ovarian Cancer Study, Ekici, Arif B., Ruebner, Matthias, Johnson, Nicola, Peto, Julian, Burwinkel, Barbara, Marme, Frederik, Brenner, Hermann, Dieffenbach, Aida K., Meindl, Alfons, Brauch, Hiltrud, Network, The GENICA, Lindblom, Annika, Depreeuw, Jeroen, Moisse, Matthieu, Chang-Claude, Jenny, Rudolph, Anja, Couch, Fergus J., Olson, Janet E., Giles, Graham G., Bruinsma, Fiona, Cunningham, Julie M., Fridley, Brooke L., Børresen-Dale, Anne-Lise, Kristensen, Vessela N., Cox, Angela, Swerdlow, Anthony J., Orr, Nicholas, Bolla, Manjeet K., Wang, Qin, Weber, Rachel Palmieri, Chen, Zhihua, Shah, Mitul, French, Juliet D., Pharoah, Paul D.P., Dunning, Alison M., Tomlinson, Ian, Easton, Douglas F., Edwards, Stacey L., Thompson, Deborah J., Spurdle, Amanda B., Dörk, Thilo , Lambrechts, Diether , Giles, Graham G , Spurdle, Amanda B , Teixeira, Manuel R , Webb, Penelope M , Hein, Alexander , Hillemanns, Peter , Swerdlow, Anthony J , Southey, Melissa C , Martin, Nicholas G , Rogatto, S R , Shu, Xiao-Ou , Dunning, Alison M , Lambrechts, Diether , Brenner, Hermann , Cox, Angela , Li, Jingmei , Ekici, Arif B , Moisse, Matthieu , Michailidou, Kyriaki , Chenevix-Trench, Georgia , Zheng, Wei , Czene, Kamila , Bowtell, David D , Batra, Jyotsna , Brauch, Hiltrud , Lindblom, Annika , Orr, Nick , Liu, Jing

Mayo Clinic

Human Molecular Genetics | November 6, 2014 | Volume: 24 | Issue: 5 | Pages: 1478-1492

10.1093/hmg/ddu552 | PMID 25378557 Get It

American Medical Society for Sports Medicine (AMSSM) position statement: interventional musculoskeletal ultrasound in sports medicine
Hall, Mederic M. , Adams, Erik , Berkoff, David J., Concoff, Andrew L. , Dexter, William W., Smith, Jay , Finnoff, Jonathan T.

Mayo Clinic

British Journal of Sports Medicine | October 20, 2014 | Volume: 49 | Issue: 3 | Pages: 145.1-150

10.1136/bjsports-2014-094219 | PMID 25330777 Get It

Background The use of diagnostic and interventional ultrasound has significantly increased over the past decade. A majority of the increased utilisation is by non-radiologists. In sports medicine, ultrasound is often used to guide interventions such as aspirations, diagnostic or therapeutic injections, tenotomies, releases and hydrodissections. Objective Critically review the literature related to the accuracy, efficacy and cost-effectiveness of ultrasound-guided injections (USGIs) in major, intermediate and small joints; and soft tissues. Design Systematic review of the literature. Results USGIs are more accurate than landmark-guided injections (LMGIs; strength of recommendation taxonomy (SORT) Evidence Rating=A). USGIs are more efficacious than LMGIs (SORT Evidence Rating=B). USGIs are more cost-effective than LMGIs (SORT Evidence Rating=B). Ultrasound guidance is required to perform many new procedures (SORT Evidence Rating=C). Conclusions The findings of this position statement indicate there is strong evidence that USGIs are more accurate than LMGI, moderate evidence that they are more efficacious and preliminary evidence that they are more cost-effective. Furthermore, ultrasound-guided (USG) is required to perform many new, advanced procedures and will likely enable the development of innovative USG surgical techniques in the future.
Verbal abuse, like physical and sexual abuse, in childhood is associated with an earlier onset and more difficult course of bipolar disorder
Post, Robert M, Altshuler, Lori L., Kupka, Ralph , Frye, Mark A. , Leverich, Gabriele S., Grunze, Heinz , Suppes, Trisha, Keck, Paul E., Nolen, Willem A. , Post, Robert M, McElroy, Susan L. , Rowe, Michael J. , Grunze, Heinz

Mayo Clinic

Bipolar Disorders | October 13, 2014 | Volume: 17 | Issue: 3 | Pages: 323-330

10.1111/bdi.12268 | PMID 25307301 Get It

Diagnosing Lysosomal Storage Disorders: The GM2 Gangliosidoses
Minnich, Sara , Teigen, Claire, Raymond, Kimiyo , Hall, Patricia

Mayo Clinic

Current Protocols in Human Genetics | October 1, 2014 | Volume: 83 | Issue: 1 | Pages: No page available

10.1002/0471142905.hg1716s83 | PMID 25271840 Get It

AbstractThe GM2 gangliosidoses are a group of autosomal recessive lysosomal storage disorders caused by defective β‐hexosaminidase. There are three clinical conditions in this group: Tay‐Sachs disease (TSD), Sandhoff disease (SD), and hexosaminidase activator deficiency. The three conditions are clinically indistinguishable. TSD and SD have been identified with infantile, juvenile, and adult onset forms. The activator deficiency is only known to present with infantile onset. Diagnosis of TSD and SD is based on decreased hexosaminidase activity and a change in the percentage of activity between isoforms. There are no biochemical tests currently available for activator deficiency. This unit provides a detailed procedure for identifying TSD and SD in affected individuals and carriers from leukocyte samples, the most robust sample type available. Curr. Protoc. Hum. Genet. 83:17.16.1‐17.16.8. © 2014 by John Wiley & Sons, Inc.
Investigation of gene‐environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors
Truong, Thérèse , Knight, Julia A. , Flesch‐Janys, Dieter, Eilber, Ursula, Bolla, Manjeet K. , Wang, Qin , Dunning, Alison M. , Shah, Mitul , Munday, Hannah, Darabi, Hatef, Eriksson, Mikael , Brand, Judith S. , Vachon, Celine M. , Hallberg, Emily, Castelao, Jose E. , Carracedo, Ángel , Torres, María , Li, Jingmei , Humphreys, Keith , Cordina‐Duverger, Emilie, Ménégaux, F. , Flyger, Henrik, Nordestgaard, Børge G. , Nielsen, Sune F. , Yesilyurt, Betül T., Floris, Giuseppe , Leunen, Karin, Engelhardt, Ellen G. , Rutgers, Emiel J. , Glendon, Gord, Mulligan, Anna Marie , Reed, Malcolm , González‐Neira, Anna , Pérez, José Ignacio Arias , Provenzano, Elena , Apicella, Carmel, Southey, Melissa C. , Investigators, kConFab, Group, AOCS, Häberle, Lothar , Beckmann, Matthias W. , Ekici, Arif B. , Dieffenbach, Aida Karina, Stegmaier, Christa, McLean, Catriona , Baglietto, Laura , Lissowska, Jolanta , Sherman, Mark E., Brüning, Thomas , Hamann, Ute, Ko, Yon‐Dschun, Orr, Nick , Schoemaker, Minouk J. , Ashworth, Alan , Kosma, Veli‐Matti , Kataja, Vesa , Hartikainen, Jaana M. , Mannermaa, Arto, Swerdlow, Anthony J. , GENICA‐Network, Giles, Graham G. , Brenner, Hermann , Fasching, Peter A. , Chenevix‐Trench, Georgia , Hopper, John L. , Benı́tez, Javier , Cox, Angela , Andrulis, Irene L. , Lambrechts, Diether , Gago-Domínguez, Manuela , Couch, Fergus J., Czene, Kamila , Bojesen, Stig E. , Easton, Doug , Schmidt, Marjanka K. , Guénel, Pascal , García‐Closas, Montserrat , Chang‐Claude, Jenny , Thorne, Heather , Lambrechts, Diether , Rudolph, Anja , Milne, Roger L. , Seibold, Petra , Behrens, Sabine , Dennis, Joe , Eriksson, Mikael , Olson, Janet E. , Vachon, Celine M. , Broeks, Annegien , Cross, Simon S. , Spurdle, Amanda B. , Investigators, kConFab, Group, AOCS, Arndt, Volker , Chanock, Stephen Jacob , Mannermaa, Arto, GENICA‐Network, Couch, Fergus J. , Hall, Per N , Pharoah, Paul D.P. , Lambrechts, Diether , Giles, Graham G , Swerdlow, Anthony J , Lissowska, Jolanta , Southey, Melissa C , Dunning, Alison M , Lambrechts, Diether , Brenner, Hermann , Cox, Angela , Gago-Dominguez, Manuela , Guénel, Pascal , Li, Jingmei , García-Closas, Montserrat , Schmidt, Marjanka K , Ekici, Arif B , Hartikainen, Jaana M , Benitez, Javier , Chenevix-Trench, Georgia , Czene, Kamila , Baglietto, Laura , Bojesen, Stig E , Schoemaker, Minouk J , Truong, Therese , Mclean, Catriona , Orr, Nick

Mayo Clinic

International Journal of Cancer | September 16, 2014 | Volume: 136 | Issue: 6 | Pages: No page available

10.1002/ijc.29188 | PMID 25227710 Get It

A large genotyping project within the Breast Cancer Association Consortium (BCAC) recently identified 41 associations between single nucleotide polymorphisms (SNPs) and overall breast cancer (BC) risk. We investigated whether the effects of these 41 SNPs, as well as six SNPs associated with estrogen receptor (ER) negative BC risk are modified by 13 environmental risk factors for BC. Data from 22 studies participating in BCAC were pooled, comprising up to 26,633 cases and 30,119 controls. Interactions between SNPs and environmental factors were evaluated using an empirical Bayes‐type shrinkage estimator. Six SNPs showed interactions with associated p ‐values ( p int ) <1.1 × 10 −3 . None of the observed interactions was significant after accounting for multiple testing. The Bayesian False Discovery Probability was used to rank the findings, which indicated three interactions as being noteworthy at 1% prior probability of interaction. SNP rs6828523 was associated with increased ER‐negative BC risk in women ≥170 cm (OR = 1.22, p = 0.017), but inversely associated with ER‐negative BC risk in women <160 cm (OR = 0.83, p = 0.039, p int = 1.9 × 10 −4 ). The inverse association between rs4808801 and overall BC risk was stronger for women who had had four or more pregnancies (OR = 0.85, p = 2.0 × 10 −4 ), and absent in women who had had just one (OR = 0.96, p = 0.19, p int = 6.1 × 10 −4 ). SNP rs11242675 was inversely associated with overall BC risk in never/former smokers (OR = 0.93, p = 2.8 × 10 −5 ), but no association was observed in current smokers (OR = 1.07, p = 0.14, p int = 3.4 × 10 −4 ). In conclusion, recently identified BC susceptibility loci are not strongly modified by established risk factors and the observed potential interactions require confirmation in independent studies.
Predictors for Glucose Change in Hypertensive Participants Following Short‐term Treatment with Atenolol or Hydrochlorothiazide
Moore, Mariellen J., Hou, Wei , Hall, Karen , Schmidt, Siegfried , Curry, Robert W., Beitelshees, Amber L. , Chapman, Arlene B. , Schwartz, Gary L. , Bailey, Kent R. , Boerwinkle, Eric , Gums, John G. , Johnson, Julie A. , Beitelshees, Amber L. , Gong, Yan , Chapman, Arlene B. , Turner, Stephen T. , Cooper‐DeHoff, Rhonda M.

Mayo Clinic

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | September 9, 2014 | Volume: 34 | Issue: 11 | Pages: 1132-1140

10.1002/phar.1483 | PMID 25202885 Get It

Study ObjectiveTo develop and validate a predictive model for glucose change and risk for new‐onset impaired fasting glucose in hypertensive participants following treatment with atenolol or hydrochlorothiazide (HCTZ).DesignRandomized multicenter clinical trial.PatientsA total of 735 white or African‐American men and women with uncomplicated hypertension.Measurements and Main ResultsPharmacogenomic Evaluation of Antihypertensive Responses (PEAR) is a randomized clinical trial to assess the genetic and nongenetic predictors of blood pressure response and adverse metabolic effects following treatment with atenolol or HCTZ. To develop and validate predictive models for glucose change, PEAR participants were randomly divided into a derivation cohort of 367 and a validation cohort of 368. Linear and logistic regression modeling were used to build models of drug‐associated glucose change and impaired fasting glucose (IFG), respectively, in the derivation cohorts. These models were then evaluated in the validation cohorts. For glucose change after atenolol or HCTZ treatment, baseline glucose was a significant (p<0.0001) predictor, explaining 13% of the variability in glucose change after atenolol and 12% of the variability in glucose change after HCTZ. Baseline glucose was also the strongest and most consistent predictor (p<0.0001) for development of IFG after atenolol or HCTZ monotherapy. The area under the receiver operating curve was 0.77 for IFG after atenolol and 0.71 after HCTZ treatment, respectively.ConclusionBaseline glucose is the primary predictor of atenolol or HCTZ‐associated glucose increase and development of IFG after treatment with either drug.